| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 37,532 | 44,091 | 43,038 | 60,706 | | Cost of Revenue | 9,797 | 12,405 | 13,930 | 15,677 | | | Gross Profit |
-
| 31,686 | 29,108 | 45,029 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 25,690 | 26,472 | 22,640 | 21,650 | | Non Recurring | (4,836) | 4,558 | 278 | (116) | | Others | 17,414 | 8,128 | 5,177 | 16,292 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| (7,472) | 1,013 | 7,203 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (10,533) | (7,472) | 1,013 | 7,203 | | Interest Expense | 1,629 | 1,612 | 1,670 | 1,984 | | Income Before Tax | (12,162) | (9,084) | (657) | 5,219 | | Income Tax Expense | (5,620) | (4,450) | (1,042) | 966 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (6,542) | (4,634) | 385 | 4,253 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (6,542) | (4,634) | 385 | 4,253 | | Preferred Stock And Other Adjustments |
-
| (4,146) | (1,205) |
-
| | | Net Income Applicable To Common Shares | ($6,542) | ($8,780) | ($820) | $4,253 |
|
0.51% Nasdaq 
Income Statement
